Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/13/17
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 01/31/14
End: 07/11/17
Due: 07/11/18
Phase: N/A
Priority: Normal
Start: 02/28/23
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/18/18
End: 02/25/22
Due: 02/25/23
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme | NCT02344355 | Bryan Allen | user2@example.com | None | 2017-03-13 | 2027-12-31 | 2028-12-31 | - | - | 2025-07-14 |
| Ketogenic Diet Phase 1 for Head & Neck Cancer | NCT01975766 | Bryan Allen | user2@example.com | None | 2014-01-31 | 2017-07-11 | 2018-07-11 | - | - | 2025-07-14 |
| A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma | NCT04900792 | Bryan Allen | user2@example.com | None | 2023-02-28 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| T2* MRI Analysis for Sarcoma | NCT03658343 | Bryan Allen | user2@example.com | None | 2018-09-18 | 2022-02-25 | 2023-02-25 | - | - | 2025-07-14 |